NCNA Gets Second Nasdaq Notice; Hearing to Delay Potential Delisting
Rhea-AI Filing Summary
NuCana plc (NASDAQ: NCNA) faces heightened delisting risk. The company disclosed that on July 8, 2025 it received a second notice from Nasdaq after its American Depositary Shares closed below $0.10 for 10 consecutive trading days (period ended July 7, 2025). This follows an earlier June 18, 2025 notice for falling below the $1.00 minimum bid price, which granted NuCana until December 15, 2025 to regain compliance. Under Nasdaq Listing Rule 5810(c)(3)(A)(iii), falling below $0.10 triggers imminent delisting unless the issuer requests a hearing.
NuCana intends to timely request a hearing before the Nasdaq Hearings Panel. The hearing request will automatically stay any suspension or delisting action pending the Panel’s decision, giving management additional time to present a compliance plan or pursue corporate actions (e.g., reverse split) to restore the share price.
No financial results, operational updates, or transactions were included; the 6-K focuses solely on the listing status. The information is incorporated by reference into the company’s existing Form F-3 and S-8 registration statements.
Positive
- The company will request a Nasdaq Hearings Panel review, automatically staying any suspension or delisting action during the appeal process.
Negative
- ADS bid price fell below $0.10 for 10 consecutive days, triggering immediate Nasdaq delisting procedures.
- Company is already out of compliance with the $1.00 minimum bid price rule, compounding listing deficiencies and increasing risk to shareholders.
Insights
TL;DR: Nasdaq $0.10 bid-price breach escalates delisting threat; hearing buys limited time.
The second Nasdaq notice materially worsens NuCana’s liquidity and capital-markets outlook. Sub-$0.10 pricing suggests diminished investor confidence and potential non-compliance with brokers’ custodial rules, further constraining trading volumes. While a hearing stay delays delisting, historically Panels grant 180-day extensions only with credible remediation plans such as a firmly scheduled reverse split. Absent rapid tangible catalysts, the risk of migration to OTC markets rises, likely pressuring the stock’s valuation and increasing financing costs.
TL;DR: Governance focus shifts to safeguarding U.S. listing; board must act swiftly.
The board now faces a time-sensitive governance challenge. Failure to maintain Nasdaq listing can limit institutional ownership, reduce transparency, and impair equity-based compensation programs referenced in the S-8 filings. The announced intent to request a hearing is procedurally correct, yet investors will expect a clearly articulated action plan—often a reverse split resolution requiring shareholder approval. Delay or indecision could signal weak governance oversight, potentially eroding stakeholder trust.
AI-generated analysis. How Rhea-AI works. Not financial advice.
